Trading Statement

NMT Group PLC 11 July 2005 NMT Group PLC Trading Update In January 2005 NMT Group PLC ('the Company') signed a letter of intent for the manufacture and distribution of its 2nd Generation retractable safety syringe in the Far East which provided for a license fee stage payment from the prospective licensing partner at the beginning of July 2005, subject to agreement of a formal contract. Although the Company remains in communication with the prospective licensing partner, to date no formal contract has been signed nor has any stage payment been received. The outcome and timing of this contract is now uncertain and outside of the Company's control. The Safety Needle Unit is production ready, with the project fully costed and sub-contract manufacturers identified. With regard to the major pharmaceutical company, which had decided to postpone proceeding with a license for the manufacture and distribution of the device following the detailed marketing study, discussions are anticipated to resume in autumn 2005, aimed at a 2007 launch. Additional discussions on licensing the Safety Needle Unit began in June with two US-based companies, one a major pharmaceutical company and the other a major medical device supplier. Both companies have expressed interest in taking the product to the next stage of their internal evaluations. The Company's balance sheet remains strong with cash at 30th June 2005 standing at £6.5million. However, given the difficulty in predicting the outcome of the above licensing discussions, the Board now intends to explore all options for maximising the value of the Company's assets as rapidly as possible, including the sale of the Company or the sale of its business operations followed by a sale or merger strategy for obtaining the best value for shareholders for the Company's cash assets. The Company will keep shareholders informed of further developments. Enquiries: Contact: Tony Fletcher Chairman NMT Group PLC Tel: 01506 445000 Mobile: 07836 725246 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings